Literature DB >> 19952318

Susceptibility to fluoroquinolones of Vibrio cholerae O1 isolated from diarrheal patients in Zimbabwe.

M Sirajul Islam1, Stanley M Midzi, Lincoln Charimari, Alejandro Cravioto, Hubert P Endtz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19952318     DOI： 10.1001/jama.2009.1750

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  Phenotypic, genotypic, and antibiotic sensitivity patterns of strains isolated from the cholera epidemic in Zimbabwe.

Authors:  Mohammad S Islam; Zahid H Mahmud; Mohammad Ansaruzzaman; Shah M Faruque; Kaisar A Talukder; Firdausi Qadri; Munirul Alam; Shafiqul Islam; Pradip K Bardhan; Ramendra N Mazumder; Azharul I Khan; Sirajuddin Ahmed; Anwarul Iqbal; Owen Chitsatso; James Mudzori; Sheetal Patel; Stanley M Midzi; Lincoln Charimari; Hubert P Endtz; Alejandro Cravioto
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 2.  Cholera.

Authors:  Jason B Harris; Regina C LaRocque; Firdausi Qadri; Edward T Ryan; Stephen B Calderwood
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

3.  Genomic diversity of 2010 Haitian cholera outbreak strains.

Authors:  Nur A Hasan; Seon Young Choi; Mark Eppinger; Philip W Clark; Arlene Chen; Munirul Alam; Bradd J Haley; Elisa Taviani; Erin Hine; Qi Su; Luke J Tallon; Joseph B Prosper; Keziah Furth; M M Hoq; Huai Li; Claire M Fraser-Liggett; Alejandro Cravioto; Anwar Huq; Jacques Ravel; Thomas A Cebula; Rita R Colwell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

4.  Multi-drug resistant Vibrio cholerae O1 variant El Tor isolated in northern Vietnam between 2007 and 2010.

Authors:  Huu Dat Tran; Munirul Alam; Nguyen Vu Trung; Nguyen Van Kinh; Hong Ha Nguyen; Van Ca Pham; Mohammad Ansaruzzaman; Shah Manzur Rashed; Nurul A Bhuiyan; Tuyet Trinh Dao; Hubert P Endtz; Heiman F L Wertheim
Journal:  J Med Microbiol       Date:  2011-10-20       Impact factor: 2.472

5.  Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.

Authors:  Wasif Ali Khan; Debasish Saha; Sabeena Ahmed; Mohammed Abdus Salam; Michael Louis Bennish
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

6.  Antimicrobial Drug Resistance of Vibrio cholerae, Democratic Republic of the Congo.

Authors:  Berthe Miwanda; Sandra Moore; Jean-Jacques Muyembe; Georges Nguefack-Tsague; Ickel Kakongo Kabangwa; Daniel Yassa Ndjakani; Ankur Mutreja; Nicholas Thomson; Helene Thefenne; Eric Garnotel; Gaston Tshapenda; Denis Kandolo Kakongo; Guy Kalambayi; Renaud Piarroux
Journal:  Emerg Infect Dis       Date:  2015-05       Impact factor: 6.883

7.  Genetic traits of Vibrio cholerae O1 Haitian isolates that are absent in contemporary strains from Kolkata, India.

Authors:  Priyanka Ghosh; Arindam Naha; G P Pazhani; T Ramamurthy; Asish K Mukhopadhyay
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

8.  Phenotypic and genetic characterization of Vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010.

Authors:  Njeru Mercy; Ahmed Abade Mohamed; Ng'ang'a Zipporah; Goutam Chowdhury; Gururaja Perumal Pazhani; Thandavarayan Ramamurthy; Hamadi I Boga; Samuel M Kariuki; Oundo Joseph
Journal:  Pan Afr Med J       Date:  2014-09-04

9.  Vibrio cholerae O1 variant with reduced susceptibility to ciprofloxacin, Western Africa.

Authors:  Marie Laure Quilici; Denis Massenet; Bouba Gake; Barem Bwalki; David M Olson
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

10.  Overcoming barriers in evaluating outbreaks of diarrheal disease in resource poor settings: assessment of recurrent outbreaks in Chobe District, Botswana.

Authors:  K A Alexander; J K Blackburn
Journal:  BMC Public Health       Date:  2013-08-26       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.